Avandia, a Drug Used to Treat Type 2 Diabetes, Has Been Linked to Heart Failure, Other Serious Health Problems

Patients taking the Type 2 diabetes drug Avandia are 43 percent more likely to suffer a heart attack and 64 percent more likely to die from a cardiovascular disease, according to medical research published in the New England Journal of Medicine. Concerns about adverse side effects caused by Avandia (rosiglitazone) prompted the Food and Drug Administration in May 2007 to warn users and physicians about the risks associated with the drug.

The FDA ordered Avandia's packaging to carry a prominent "Black Box"� warning, the strongest such safety advisory the agency can order, about the risks of heart attack and cardiovascular complications linked to the drug. Since the drug was approved in 1992, Avandia has become the most popular Type 2 diabetes drug in the world, taken by more 10 million Americans with the blood-sugar disease.

Possible Avandia Related Injuries

• Liver failure and liver damage
• Fluid in the lungs (Pulmonary edema)
• Swelling of the eye (Macular edema)
• Swollen legs or ankles
• Rapid, unexplained weight gain
• Tiredness
• Low blood pressure
• Changes in vision
• Shortness of breath
• Difficulty breathing
• Chest pains
• Dizziness

Avandia Linked To Heart Failure!

Heart failure, a condition in which the heart can no longer effectively circulate blood through the body, is the most serious injury associated with the use of Avandia. Heart failure often leads to deadly heart attacks, strokes, and other life-threatening injuries.

If you or a loved one took Avandia for the treatment of Type 2 diabetes and suffered a heart attack, liver damage, or other health complications, we encourage you to contact experienced legal counsel as soon as possible to determine your possible legal rights to financial compensation for your injuries. For more information and a survey to see if you qualify click this link